Baystate Health Opioid Overdose Program Initiated
Posted in Updates on 6.22.2017
A team of researchers at Baystate Health led by principle investigators Dr. Peter Friedmann and Dr. Josiah D. Rich have contracted with Alosa Health to implement a study testing academic detailing as a means to increase naloxone and buprenorphine prescribing in HIV treatment settings. Impetus for this study comes from previous research demonstrating high rates of opioid overdose among people living with HIV. Baystate researchers hypothesize that HIV physicians, given proper training, might be willing to integrate naloxone prescribing into their practice to prevent overdose death among patients.
Alosa Health is thrilled to work in tandem with this group to help execute the academic detailing component of the study.